Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

New Synthetic Antispasmodics

Abstract

A RECENT publication1 prompts us to report the preparation of a number of novel synthetic antispasmodics related to papaverine. The numerous synthetic analogues of papaverine (I) which have been prepared (see, for example, Blicke2) can be divided into two main groups : (1) those with an intact isoquinoline ring system (for example, eupaverine3) and (2) those in which the isoquinoline ring has been opened at the line aa to give a bis-(2-phenylethyl)amine (for example, sestron4).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Heinzelman and Aspergren, J. Amer. Chem. Soc., 75, 3409 (1953).

    Article  Google Scholar 

  2. Blicke, Ann. Rev. Biochem., 13, 549 (1944).

    Article  CAS  Google Scholar 

  3. Kreitmair, Arch. Exp. Pathol. Pharmakol., 164, 509 (1932).

    Article  CAS  Google Scholar 

  4. Külz and Rosenmund, Klin. Wochschr., 17, 345 (1938).

    Article  Google Scholar 

  5. Mercier, Lespagnol and Mercier, C.R. Soc. Biol., 143, 1123 (1949).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

CYMERMAN-CRAIG, J., MARTIN, K., WAILES, P. et al. New Synthetic Antispasmodics. Nature 174, 231 (1954). https://doi.org/10.1038/174231a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/174231a0

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing